Evidence map›Paper›PMID 19169862›Full record

ArticleInternational ophthalmology2010

Role of residual vitreous cortex removal in prevention of postoperative vitreous hemorrhage in diabetic vitrectomy.

Rizwan A Cheema, Javed Mushtaq, Maheera A Cheema

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Rizwan A CheemaVitreo-Retinal Service, Dhahran Eye Specialist Hospital, Dhahran, KSA. drrac@doctors.net.uk
Javed Mushtaq
Maheera A Cheema
Cardiff University · GBDhahran Health Center · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate whether residual vitreous cortex removal has a role in the prevention of postoperative vitreous hemorrhage in diabetic vitrectomy.

methodsRetrospective, comparative, nonrandomized study on a consecutive series of patients who underwent vitrectomy for diabetic eye disease. Recurrence of postoperative vitreous hemorrhage was compared in patients following surgery with and without residual vitreous cortex removal.

resultsDuring the study period, 59 patients had vitrectomy for diabetic disease. In 31 patients (group 1), the residual vitreous cortex was not removed and in 28 patients (group 2) the residual vitreous cortex was removed during surgery. Both groups were matched for number of patients, age, sex, duration of follow-up, and diagnosis. Recurrent postoperative vitreous hemorrhage (RVH) was noted in ten patients in group 1 (10/31, 32.25%) and in two patients in group 2 (2/28, 7.14%). The difference in postoperative vitreous hemorrhage between the two groups was statistically significant (P = 0.017). Logistic regression analysis showed that residual vitreous cortex removal and presence of intravitreal gas tamponade were associated with reduced risk of postoperative vitreous hemorrhage. However, only residual vitreous cortex removal was statistically significant factor in reducing risk of postoperative vitreous hemorrhage [odds ratio = 0.174; confidence interval (CI) = 0.0331-0.919; P = 0.040].

conclusionResidual vitreous cortex removal may be beneficial in reducing recurrence of postoperative vitreous hemorrhage following diabetic vitrectomy. Further randomized studies should be performed to evaluate the potential of this surgical technique in preventing postoperative recurrent vitreous hemorrhage following diabetic vitrectomy.

Indexed as

AdultAgedAged, 80 and overDiabetic RetinopathyFemaleHumansMaleMiddle AgedPostoperative ComplicationsRetinal DetachmentRetrospective StudiesRiskTreatment OutcomeVisual AcuityVitrectomyVitreous Body

Identifiers

PMID19169862
OpenAlexW1990985036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.